SIMR Announces Achievement of SR1375 Milestone for Chinese P
On 26th Dec 2022, Shanghai SIMR Biotechnology Co., Ltd. (hereinafter “SIMR”) announced that SR1375, a drug candidate for the treatment of diabetic retinopathy with a new mechanism of action, that is i...
